Scarica l'app Stockscreener
129.57
0.71%
-1.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$130.85
Aprire:
$129.77
Volume 24 ore:
244.14K
Relative Volume:
0.32
Capitalizzazione di mercato:
$4.45B
Reddito:
$605.49M
Utile/perdita netta:
$190.29M
Rapporto P/E:
26.68
EPS:
4.8571
Flusso di cassa netto:
$133.59M
1 W Prestazione:
-12.01%
1M Prestazione:
-2.53%
6M Prestazione:
+11.05%
1 anno Prestazione:
+92.05%
Intervallo 1D:
$128.66
$132.19
Intervallo di 1 settimana:
$122.38
$147.50
Portata 52W:
$62.23
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
129.60 | 4.49B | 605.49M | 190.29M | 133.59M | 4.8571 |
|
ABT
Abbott Laboratories
|
110.14 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
346.56 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.81 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.80 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Aggiornamento | Needham | Hold → Buy |
| 2025-10-13 | Iniziato | Jefferies | Buy |
| 2025-09-16 | Iniziato | Evercore ISI | Outperform |
| 2025-09-04 | Iniziato | Stifel | Hold |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
Blair William & Co. IL Lowers Stake in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics group CFO Hernandez sells shares worth $1.12 million By Investing.com - Investing.com Nigeria
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect - ACCESS Newswire
TransMedics group CFO Hernandez sells shares worth $1.12 million - Investing.com
(TMDX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Fieldview Capital Management LLC Acquires New Position in TransMedics Group, Inc. $TMDX - MarketBeat
Got $5,000? TransMedics Could Be a High‑Tech Organ Transplant Moonshot - AOL.com
12 Best Under-the-Radar Stocks to Buy According to Hedge Funds - Insider Monkey
TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade) (TMDX) - Seeking Alpha
TransMedics Group (TMDX) Analyst Ratings Update: Stifel Raises P - GuruFocus
TransMedics: Numb Reaction To Extraordinary Fundamentals (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $130.00 - MarketBeat
Stifel raises TransMedics stock price target to $130 on liver strength - Investing.com
Assessing TransMedics Group (TMDX) Valuation After Recent Short Term Share Price Weakness - Yahoo Finance
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? - The Motley Fool
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? - The Motley Fool
4 Top Stocks Long-Term Investors Should Buy in March - The Globe and Mail
Lovell, TransMedics director, sells $178k in TMDX stock - Investing.com Nigeria
Weill David sells TransMedics (TMDX) shares worth $524,294 - Investing.com Nigeria
Weill David sells TransMedics (TMDX) shares worth $524,294 By Investing.com - Investing.com India
Insider Sell: Stephanie Lovell Sells Shares of TransMedics Group Inc (TMDX) - GuruFocus
Stephanie Lovell Sells 1,193 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
TransMedics Group (NASDAQ:TMDX) Director David Weill Sells 3,571 Shares - MarketBeat
TransMedics Group Signals Strong Growth in Earnings Call - TipRanks
TransMedics Group Inc. (NASDAQ:TMDX) Combines Strong Earnings Momentum with Bullish Technical Setup - ChartMill
A Look At TransMedics Group (TMDX) Valuation After Strong Results And Optimistic Revenue Guidance - simplywall.st
Anil Ranganath Sells 864 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
Insider Selling: TransMedics Group (NASDAQ:TMDX) CFO Sells 375 Shares of Stock - MarketBeat
Nicholas Corcoran Sells 2,966 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
TransMedics Group (NASDAQ:TMDX) CFO Sells $1,065,211.56 in Stock - MarketBeat
The medtech firm’s latest quarter showed organ demand – and profits – continuing to rise. - Finimize
TransMedics Group, Inc. $TMDX Shares Acquired by DNB Asset Management AS - MarketBeat
Why TransMedics Group (TMDX) Is Up 9.2% After Strong 2025 Results And 2026 Outlook - Sahm
TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth with a 54.24% Return on Equity - DirectorsTalk Interviews
TransMedics Group, Inc. $TMDX Shares Acquired by Citigroup Inc. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
TD Cowen Health Care Conference - marketscreener.com
TransMedics Stock Soars After Beating Revenue Expectations and Raising Guidance - timothysykes.com
Wall Street Zen Downgrades TransMedics Group (NASDAQ:TMDX) to Hold - MarketBeat
TransMedics Shares Surge Amid Strong Q4 Financial Performance - StocksToTrade
TransMedics’ Shares Surge on Strong Q4 Results and Price Target Raises - StocksToTrade
TransMedics Stock Surges as Analysts Raise Price Targets Amid Strong Earnings - timothysykes.com
TransMedics Stock Surges After Outstanding Q4 Earnings and Strategic Expansion Plans - StocksToTrade
TransMedics Group (NASDAQ:TMDX) Shares Up 5.9%What's Next? - MarketBeat
Vanguard Group Inc. Buys 9,650 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics provides information on impact of release of valuation allowance on deferred tax assets on previously reported quarterly results - marketscreener.com
TransMedics clarifies Q4 tax benefit impact on earnings - Investing.com
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results - PR Newswire
Analysts’ Top Healthcare Picks: Vaxcyte (PCVX), TransMedics Group (TMDX) - The Globe and Mail
TransMedics Group, Inc. (TMDX): A bull case theory - MSN
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? - Yahoo Finance
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
0.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):